scispace - formally typeset
S

Suzanne Oparil

Researcher at University of Alabama at Birmingham

Publications -  941
Citations -  122414

Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.

Papers
More filters
Journal ArticleDOI

The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.

TL;DR: The hypothesis that endogenous ET-1 plays a major role in hypoxic pulmonary vasoconstriction/hypertension, right heart hypertrophy, and pulmonary vascular remodeling is supported and it is suggested that ET-A receptor blockers may be useful in the treatment and prevention of hypoxia-induced pulmonary hypertension in humans.
Journal ArticleDOI

Apparent treatment resistant hypertension and risk for stroke, coronary heart disease and all-cause mortality

TL;DR: Assessment of the association ofarent treatment-resistant hypertension with incident stroke, coronary heart disease, and all-cause mortality in Participants from the population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) Study found aTRH was associated with an increased risk for coronaryHeart disease and all thecause mortality.
Journal ArticleDOI

Estrogen modulates TNF-α-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-β activation

TL;DR: This data indicates that 17β-estradiol attenuates responses to endoluminal injury of the rat carotid artery, at least in part, by decreasing inflammatory mediator expression and neutrophi...
Journal ArticleDOI

Adherence and persistence with taking medication to control high blood pressure

TL;DR: Improvements in adherence and persistence are likely to be achieved by supporting patient self-management, a team approach to patient care, technology-supported office practice systems, better methods to measure adherence, and less clinical inertia.